|
1
|
Zhao D, Liu J, Wang M, Zhang X and Zhou M:
Epidemiology of cardiovascular disease in China: Current features
and implications. Nat Rev Cardiol. 16:203–212. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nemet I, Saha PP, Gupta N, Zhu W, Romano
KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y, et al: A cardiovascular
disease-linked gut microbial metabolite acts via adrenergic
receptors. Cell. 180:862–877.e22. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Roth GA, Johnson C, Abajobir A, Abd-Allah
F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, et al:
Global, regional, and national burden of cardiovascular diseases
for 10 causes, 1990 to 2015. J Am Coll Cardiol. 70:1–25.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bajaj A and Sethi A, Rathor P, Suppogu N
and Sethi A: Acute complications of myocardial infarction in the
current era: Diagnosis and management. J Investig Med. 63:844–855.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Boateng S and Sanborn T: Acute myocardial
infarction. Dis Mon. 59:83–96. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Guo X, Li Z, Vittinghoff E, Sun Y and
Pletcher MJ: Trends in rate of acute myocardial infarction among
patients aged <30 years. Nat Rev Cardiol. 15(119)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Arora S, Stouffer GA, Kucharska-Newton AM,
Qamar A, Vaduganathan M, Pandey A, Porterfield D, Blankstein R,
Rosamond WD, Bhatt DL and Caughey MC: Twenty year trends and sex
differences in young adults hospitalized with acute myocardial
infarction. Circulation. 139:1047–1056. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bob-Manuel T, Ifedili I, Reed G, Ibebuogu
UN and Khouzam RN: Non-ST elevation acute coronary syndromes: A
comprehensive review. Curr Probl Cardiol. 42:266–305.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Friess U and Stark M: Cardiac markers: A
clear cause for point-of-care testing. Anal Bioanal Chem.
393:1453–1462. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Morrow DA, Cannon CP, Jesse RL, Newby LK,
Ravkilde J, Storrow AB, Wu AH and Christenson RH: National Academy
of Clinical Biochemistry. National academy of clinical biochemistry
laboratory medicine practice guidelines: Clinical characteristics
and utilization of biochemical markers in acute coronary syndromes.
Circulation. 115:e356–e375. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Leisy PJ, Coeytaux RR, Wagner GS, Chung
EH, McBroom AJ, Green CL, Williams JW Jr and Sanders GD: ECG-based
signal analysis technologies for evaluating patients with acute
coronary syndrome: A systematic review. J Electrocardiol. 46:92–97.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Takagi H, Tanaka R, Nagata K, Ninomiya R,
Arakita K, Schuijf JD and Yoshioka K: Diagnostic performance of
coronary CT angiography with ultra-high-resolution CT: Comparison
with invasive coronary angiography. Eur J Radiol. 101:30–37.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fung E, Järvelin MR, Doshi RN, Shinbane
JS, Carlson SK, Grazette LP, Chang PM, Sangha RS, Huikuri HV and
Peters NS: Electrocardiographic patch devices and contemporary
wireless cardiac monitoring. Front Physiol. 6(149)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pyati AK, Devaranavadagi BB, Sajjannar SL,
Nikam SV, Shannawaz M and Sudharani : Heart-type fatty acid
binding protein: A better cardiac biomarker than CK-MB and
myoglobin in the early diagnosis of acute myocardial infarction. J
Clin Diagn Res. 9:BC08–BC11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ye XD, He Y, Wang S, Wong GT, Irwin MG and
Xia Z: Heart-type fatty acid binding protein (H-FABP) as a
biomarker for acute myocardial injury and long-term post-ischemic
prognosis. Acta Pharmacol Sin. 39:1155–1163. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen L, Guo X and Yang F: Role of
heart-type fatty acid binding protein in early detection of acute
myocardial infarction in comparison with cTnI, CK-MB and myoglobin.
J Huazhong Univ Sci Technolog Med Sci. 24:449–451, 459.
2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Neumann JT, Soerensen N, Schwemer T, Ojeda
F, Keller T, Renne T, Than M, Parsonage W, Schnabel R, Cullen L, et
al: Rapid measurement of a single troponin I combined with negative
ECG allow accurate rule-out of NSTEMI in patients with suspected
AMI. In: Coronary artery disease, acute coronary syndromes, acute
cardiac care. ESC Congress, Rome, Italy, p979, 2016.
|
|
18
|
Wang Y, Yang Y, Chen C, Wang S, Wang H,
Jing W and Tao N: One-step digital immunoassay for rapid and
sensitive detection of cardiac troponin I. ACS Sens. 5:1126–1131.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pöyhönen P, Kylmälä M, Vesterinen P,
Kivistö S, Holmström M, Lauerma K, Väänänen H, Toivonen L and
Hänninen H: Peak CK-MB has a strong association with chronic scar
size and wall motion abnormalities after revascularized
non-transmural myocardial infarction-a prospective CMR study. BMC
Cardiovasc Disord. 18(27)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Newby LK, Goldmann BU and Ohman EM:
Troponin: An important prognostic marker and risk-stratification
tool in non-ST-segment elevation acute coronary syndromes. J Am
Coll Cardiol. 41 (4 Suppl S):31S–36S. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Reiter M, Twerenbold R, Reichlin T,
Mueller M, Hoeller R, Moehring B, Haaf P, Wildi K, Merk S, Bernhard
D, et al: Heart-type fatty acid-binding protein in the early
diagnosis of acute myocardial infarction. Heart. 99:708–714.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Meng X, Ming M and Wang E: Heart fatty
acid binding protein as a marker for postmortem detection of early
myocardial damage. Forensic Sci Int. 160:11–16. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Henderson WA, Xiang L, Fourie NH, Abey SK,
Ferguson EG, Diallo AF, Kenea ND and Kim CH: Simple lateral flow
assays for microbial detection in stool. Anal Methods.
10:5358–5363. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Huang X, Aguilar ZP, Xu H, Lai W and Xiong
Y: Membrane-based lateral flow immunochromatographic strip with
nanoparticles as reporters for detection: A review. Biosens
Bioelectron. 75:166–180. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang Z, Zheng Z, Hu H, Zhou Q, Li X, Liu
W, Li X, Liu Z, Wang Y and Ma Y: A point-of-care selenium
nanoparticle-based test for the combined detection of
anti-SARS-CoV-2 IgM and IgG in human serum and blood. Lab Chip.
20:4255–4261. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Frens G: Controlled nucleation for the
regulation of the particle size in monodisperse gold suspensions.
Nat Phys Sci. 241:20–22. 1973.
|
|
27
|
Horisberger M and Rosset J: Colloidal
gold, a useful marker for transmission and scanning electron
microscopy. J Histochem Cytochem. 25:295–305. 1977.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Xu LQ, Yang YM, Tong H and Xu CF: Early
diagnostic performance of heart-type fatty acid binding protein in
suspected acute myocardial infarction: Evidence from a
meta-analysis of contemporary studies. Heart Lung Circ. 27:503–512.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Anaya P and Moliterno DJ: The evolving
role of cardiac troponin in the evaluation of cardiac disorders.
Curr Cardiol Rep. 15(420)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang Y, Zheng K, Zhan W, Huang L, Liu Y,
Li T, Yang Z, Liao Q, Chen R, Zhang C and Wang Z: Highly effective
stabilization of Cd and Cu in two different soils and improvement
of soil properties by multiple-modified biochar. Ecotoxicol Environ
Saf. 207(111294)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fathil MF, Md Arshad MK, Gopinath SC,
Hashim U, Adzhri R, Ayub RM, Ruslinda AR, Nuzaihan MNM, Azman AH,
Zaki M and Tang TH: Diagnostics on acute myocardial infarction:
Cardiac troponin biomarkers. Biosens Bioelectron. 70:209–220.
2015.PubMed/NCBI View Article : Google Scholar
|
